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b Departments of Botany and Zoology, University of British Columbia, Vancouver, BC, CanadaTumor development is a multifactorial process, inﬂuenced by both speciﬁc microbial signature. These ﬁndings will require veriﬁcation in
genetic and environmental pressures. A small number of chronic
infectious agents have been designated carcinogenic, including viruses
(hepatitis B, C and HPV), bacteria (Helicobacter pylori) and parasites
(De Martel et al., 2012). Further, general microbial dysbiosis can con-
tribute to the development of some cancers (Garrett, 2015), including
in the biliary system (Avilés-Jiménez et al., 2016). In the Southeast
Asian countries Thailand, Laos, Vietnam, and Cambodia, the liver ﬂuke
Opisthorchis viverrini is endemic, and chronic infection with this trema-
tode is a known risk factor for development of the bile duct cancer
cholangiocarcinoma (CCA). Understanding how O. viverrini infection
contributes to CCA development or progression could lead to new
therapeutic interventions for this notoriously hard to treat disease.
Multiple O. viverrini infection-induced pathways have been
associated with tumorigenesis, including parasite secretion of a
growth factor that facilitates wound healing, angiogenesis and cellu-
lar proliferation that contributes to transformation of bile duct
cholangiocytes (Smout et al., 2015, 2009) and infection-induced
chronic inﬂammation (Sripa et al., 2012). This is reminiscent of a
growing number of inﬂammation-driven cancers that involve bacte-
rial dysbiosis (Garrett, 2015). However, the local tissue microbiome
has been an understudied component of CCA. Recent studies using
a small animal model of O. viverrini-induced CCA demonstrated
that ﬂuke infection of Syrian golden hamsters altered commensal
bacterial communities in the gastrointestinal tract and allowed
translocation of several microbes into bile ﬂuid (Plieskatt et al.,
2013), indicating that microbial shifts associated with O. viverrini
infection may inﬂuence CCA.
In this issue of EBioMedicine, Chng et al. (Chng et al., 2016) interro-
gate the microbiome of bile ducts isolated from O. viverrini-naïve and
-infected CCA patients and report a number of distinct features in the
bacterial composition of local tissues. All bile duct samples from CCA
patients, independent of O. viverrini infection, harbor similar microbial
communities comprised of taxa typically found in the gut. Based on
comparison of these tumor samples to hepatic and gastric tissues of
non-CCA patients, the authors suggest the existence of a bile duct-DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.04.034.
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sample numbers. Despite the gross similarities between O. viverrini-
naïve and -infected CCA bile duct microbiomes, Chng et al. identify
microbial alterations that stratify based on O. viverrini status. In
O. viverrini-naïve tumor samples, the genus Stenotrophomonas (a pro-
inﬂammatory γ-proteobacter) was enriched. Notably, ﬂuke-infected
samples have higher abundance and prevalence of Biﬁdobacteria,
which has been previously shown to produce high levels of bile salt
hydrolase (BSH) and contribute to elevated levels of carcinogenic bile
salt metabolic products (Sagar et al., 2015). However, in contrast to
what has been seen in colon cancer, CCA tumors and adjacent non-
cancerous hepatic tissue harbor very similar microbes, indicating that
CCA-associated microbiome changes are systemic rather than tumor-
speciﬁc. Together, the ﬂuke-induced microbial changes reported by
Chng et al. add to the growing body of literature demonstrating that hel-
minths can alter themicrobiotawithinmammalian hosts and show that
the ability of helminths to modulate bacterial communities extends be-
yond the gut.
A ﬁnalmodel is presented to suggest that the alteredmicrobial com-
position of theO. viverrini-infected bile ductmay promote tumor devel-
opment. Speciﬁcally, the authors propose that O. viverrini infection and
colonization of bile ducts with Biﬁdobacteria fosters a carcinogenic mi-
croenvironment through bacterial metabolic activity, suggesting that
increased accumulation of bile acids and ammonia could enhance in-
ﬂammation or genomic instability, similar to what has been reported
in colitis-associated colorectal cancer (Louis et al., 2014). Together, the
results implicate parasite and host interactions in the dysregulation of
local physiology that contributes to carcinogenesis as O. viverrini alters
the bile duct environment and promotes the proliferation of a new
bacterial player (Biﬁdobacteria). Although the ﬁndings from these
patient-based studies are intriguing, many questions regarding the rel-
ative contribution and mechanisms by which local microbiome shifts
may inﬂuence the development or progression of CCA in the context
of O. viverrini infection remain to be addressed.
We highlight the need for future studies to employ careful sampling
design and to analyze microbial data with prudence. In the context of
comparing CCA-associated bile ducts to healthy tissues and the poten-
tial mechanistic link that underlies O. viverrini infection, dysbiosis, and
promotion of a carcinogenic microenvironment, the ﬁndings by Chngthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
13L.C. Osborne, L. WegenerParfrey / EBioMedicine 8 (2016) 12–13et al. must be interpretedwith caution, asmust all associational studies.
In particular, the enrichment of speciﬁcmicrobes within human tumors
should not be considered causative for tumorigenesis, progression or
severity (Garrett, 2015). Nonetheless, the value of patient-based epide-
miological studies is the provision of testable hypotheses for basic
science experiments to determine the contribution, if any, of noted
associations. The manuscript by Chng et al. should entice further inves-
tigation of how O. viverrini infection can affect microbial communities,
the microbial metabolome, and the local immune microenvironment
in CCA development and progression.
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